Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial.
Monjazeb AM, Daly ME, Luxardi G, Maverakis E, Merleev AA, Marusina AI, Borowsky A, Mirhadi A, Shiao SL, Beckett L, Chen S, Eastham D, Li T, Vick LV, McGee HM, Lara F, Garcia L, Morris LA, Canter RJ, Riess JW, Schalper KA, Murphy WJ, Kelly K. Monjazeb AM, et al. Among authors: maverakis e. Nat Commun. 2023 Sep 2;14(1):5332. doi: 10.1038/s41467-023-40813-w. Nat Commun. 2023. PMID: 37658083 Free PMC article. Clinical Trial.
A Practical and Safe Model of Nitrogen Mustard Injury in Cornea.
Sandoval-Castellanos AM, Ke Y, Dam TM, Maverakis E, Mannis MJ, Wang XJ, Zhao M. Sandoval-Castellanos AM, et al. Among authors: maverakis e. bioRxiv [Preprint]. 2024 Oct 22:2024.10.18.619116. doi: 10.1101/2024.10.18.619116. bioRxiv. 2024. PMID: 39484372 Free PMC article. Preprint.
Immune Cell Dynamics in EGFR-Mutated NSCLC Treated With Afatinib and Pembrolizumab: Results From a Phase IB Study.
Riess JW, Lara MS, Lopez de Rodas M, Luxardi G, Herbert S, Shimoda M, Kelly K, Meerlev A, Moore E, Beckett L, Monjazeb A, Schalper K, Maverakis E, Gandara DR. Riess JW, et al. Among authors: maverakis e. JTO Clin Res Rep. 2024 Jul 14;5(10):100706. doi: 10.1016/j.jtocrr.2024.100706. eCollection 2024 Oct. JTO Clin Res Rep. 2024. PMID: 39318388 Free PMC article.
Systemic immunostimulation induces glucocorticoid-mediated thymic involution succeeded by rebound hyperplasia which is impaired in aged recipients.
Collins CP, Khuat LT, Sckisel GD, Vick LV, Minnar CM, Dunai C, Le CT, Curti BD, Crittenden M, Merleev A, Sheng M, Chao NJ, Maverakis E, Rosario SR, Monjazeb AM, Blazar BR, Longo DL, Canter RJ, Murphy WJ. Collins CP, et al. Among authors: maverakis e. Front Immunol. 2024 Sep 9;15:1429912. doi: 10.3389/fimmu.2024.1429912. eCollection 2024. Front Immunol. 2024. PMID: 39315105 Free PMC article.
Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration.
Traidl-Hoffmann C, Afghani J, Akdis CA, Akdis M, Aydin H, Bärenfaller K, Behrendt H, Bieber T, Bigliardi P, Bigliardi-Qi M, Bonefeld CM, Bösch S, Brüggen MC, Diemert S, Duchna HW, Fähndrich M, Fehr D, Fellmann M, Frei R, Garvey LH, Gharbo R, Gökkaya M, Grando K, Guillet C, Guler E, Gutermuth J, Herrmann N, Hijnen DJ, Hülpüsch C, Irvine AD, Jensen-Jarolim E, Kong HH, Koren H, Lang CCV, Lauener R, Maintz L, Mantel PY, Maverakis E, Möhrenschlager M, Müller S, Nadeau K, Neumann AU, O'Mahony L, Rabenja FR, Renz H, Rhyner C, Rietschel E, Ring J, Roduit C, Sasaki M, Schenk M, Schröder J, Simon D, Simon HU, Sokolowska M, Ständer S, Steinhoff M, Piccirillo DS, Taïeb A, Takaoka R, Tapparo M, Teixeira H, Thyssen JP, Traidl S, Uhlmann M, van de Veen W, van Hage M, Virchow C, Wollenberg A, Yasutaka M, Zink A, Schmid-Grendelmeier P. Traidl-Hoffmann C, et al. Among authors: maverakis e. Allergy. 2024 Oct;79(10):2605-2624. doi: 10.1111/all.16247. Epub 2024 Aug 4. Allergy. 2024. PMID: 39099205 Free article. Review.
Pemphigus-Associated Desmoglein-Specific IgG1 and IgG4 Have a Dominant Agalactosylated Glycan Modification.
Oloumi A, Le ST, Liu Y, Herbert S, Ji-Xu A, Merleev AA, Kruglinskaya O, Artounian K, Park D, Marusina AI, Zone JJ, Feldman R, Lebrilla CB, Maverakis E. Oloumi A, et al. Among authors: maverakis e. J Invest Dermatol. 2024 Nov;144(11):2584-2587.e6. doi: 10.1016/j.jid.2024.03.044. Epub 2024 Jun 5. J Invest Dermatol. 2024. PMID: 38848987 Free article. No abstract available.
231 results